Exclusive cooperation between ADREXpharma and Mother Labs Launch of the premium cannabis flower brand "Mother Labs" October 2024

Koblenz, Saskatchewan – [30 .09.2024] – ADREXpharma, a leading pharmaceutical company known for its expertise in the development, distribution and commercialization of medical cannabis, and Mother Labs, a leading Canadian IP and genetics company, are pleased to announce their strategic partnership. Together, they will launch a premium line of cannabis flowers on the German market under the name “Mother Labs”, offering medical patients unparalleled quality and innovation.

This exclusive collaboration combines ADREXpharma’s extensive experience in pharmaceutical distribution, regulatory affairs and market dynamics with Mother Labs’ cutting-edge genetics development and cross-breeding expertise. “This partnership represents a significant milestone in our mission to provide German patients with the highest quality medical cannabis products,” said Nicole Broockmann, CEO of ADREXpharma. “Mother Labs’ advanced genetic development capabilities perfectly complement our expertise in sales and regulatory affairs. Together we will launch a Mother Labs line that meets the highest standards of quality and consistency.”

Since the legalization of cannabis in 2019, Mother Labs has worked with many of Canada’s leading producers and supplied the market with over 150 different genetics. The company has also established a strong presence in international markets, including the UK, Australia and South Africa. Their continuous testing and expanding genetic resources are driving innovation, making this partnership with ADREXpharma a significant step in providing world-class medicinal flowers.

The new flower line of the “Mother Labs” brand will initially be launched with a hand-picked selection of premium cannabis flowers, consisting of 3 varieties developed by Mother Labs in 2024.

The first 3 genetics will be available in all German pharmacies in October 2024.

ADREXpharma and Mother Labs are committed to maintaining the highest standards of compliance, quality control and customer satisfaction as they expand their presence in the European market.